BiotechTube

Zolpidem MR + Zolpidem

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Sleep Initiation and Maintenance Disorders

Conditions

Sleep Initiation and Maintenance Disorders, Sleep Disorders

Trial Timeline

Feb 1, 2006 → Nov 1, 2007

NCT ID
NCT00283946

About Zolpidem MR + Zolpidem

Zolpidem MR + Zolpidem is a phase 3 stage product being developed by Astellas Pharma for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00283946. Target conditions include Sleep Initiation and Maintenance Disorders, Sleep Disorders.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00283946Phase 3Completed

Competing Products

20 competing products in Sleep Initiation and Maintenance Disorders

See all competitors
ProductCompanyStageHype Score
Daridorexant + PlaceboIdorsiaPhase 1
28
LY2422347 + placeboEli LillyPhase 2
52
LY2624803 - Solution + LY2624803 - Capsule + Placebo - Solution + Placebo - CapsuleEli LillyPhase 1
33
Zolpidem MR + EstazolamAstellas PharmaApproved
85
zolpidem MR + nitrazepam + placeboAstellas PharmaPhase 3
77
FK199B + ZolpidemAstellas PharmaPhase 3
77
Zolpidem MR + Zolpidem IRAstellas PharmaApproved
85
Sivopixant + Placebo + Acetazolamide + SASS-001ShionogiPhase 2
52
Placebo + Lemborexant 10 mg + Lemborexant 25 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
Lemborexant + PlaceboEisaiApproved
85
Zonisamide + PlaceboEisaiPhase 2
52
Lemborexant 2.5 mg + Lemborexant 5 mg + Lemborexant 10 mg + Lemborexant 15 mg + Lemborexant-matched placeboEisaiPhase 2
52
Placebo + Lemborexant 10 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
LemborexantEisaiPhase 2
52
Lemborexant + PlaceboEisaiPhase 3
77
LemborexantEisaiPre-clinical
23
Istradefylline (KW-6002)Kyowa KirinPhase 2
52
Eloralintide + PlaceboEli LillyPhase 3
77
Tirzepatide + PlaceboEli LillyPhase 3
77
Eszopiclone + PlaceboSumitomo PharmaPhase 2
52

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85